The function of the bcl-x promoter in erythroid progenitor cells

被引:13
|
作者
Tian, CX
Gregoli, P
Bondurant, M
机构
[1] Vet Affairs Med Ctr, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
关键词
D O I
10.1182/blood-2002-04-1217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The protein Bcl-x(L) is essential for survival of erythroid progenitor cells, and it increases substantially during late erythrocyte differentiation due to an increase of mRNA. We mapped the transcription start, sites of bcl-x mRNA in mouse and human erythroblasts, and we analyzed the function of the mouse bcl-x promoter by transient and stable transfection assays in a mouse erythroid cell line using plasmids containing the bcl-x promoter fused to a luciferase reporter gene. In mouse erythroblasts, a cluster of start sites at positions -664, -655, and -644 relative to the ATG initiation codon account for almost all transcripts. Human erythroblasts exhibit a start site at -654 that is homologous to the triplet in the mouse. A short sequence element in the mouse bcl-x promoter that includes nucleotides -1804 through -1734 was identified. as very important for transcription. This element also showed strong enhancerlike activity in concert with the SV40 promoter in an enhancer test vector. Analyses of mutations indicated that 2 short sequences within the element, about 15 base pair apart, are necessary for full enhancer activity. Gel shift experiments with oligonucleotides representing these sequences revealed specific binding of nuclear proteins from erythroblasts. Some of these proteins are regulated during the late erythroid differentiation.
引用
收藏
页码:2235 / 2242
页数:8
相关论文
共 50 条
  • [31] Newly-identified Bcl-xγ regulates apoptosis in T-cells
    Yang, XF
    Weber, GF
    Cantor, H
    FASEB JOURNAL, 1998, 12 (05): : A927 - A927
  • [32] bcl-x gene and its regulation on apoptosis
    Chen, YC
    Zhou, KY
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1999, 26 (06) : 534 - 536
  • [33] Bcl-x and the regulation of survival in the immune system
    Timothy W. Behrens
    Daniel L. Mueller
    Immunologic Research, 1997, 16 : 149 - 160
  • [34] Kaposi's sarcoma tumor cells preferentially express Bcl-x(L)
    Foreman, KE
    WroneSmith, T
    Boise, LH
    Thompson, CB
    Polverini, PJ
    Simonian, PL
    Nunez, G
    Nickoloff, BJ
    AMERICAN JOURNAL OF PATHOLOGY, 1996, 149 (03): : 795 - 803
  • [35] Kaposi's sarcoma (KS) tumor cells overexpress BCL-X(L).
    Nunez, G
    Foreman, K
    Clarke, M
    WroneSmith, T
    Boise, L
    Thompson, C
    Polverini, P
    Apel, I
    Simonian, P
    Nickoloff, B
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 106 (04) : 565 - 565
  • [36] Bcl-X is present in benign plasma cells and absent in the majority of plasmacytic neoplasms
    Berean, K
    Gascoyne, R
    Krajewski, S
    Krajewska, M
    Reed, JC
    LABORATORY INVESTIGATION, 1997, 76 (01) : 699 - 699
  • [37] Withdrawal: Glucocorticoids repress bcl-X expression in lymphoid cells by recruiting STAT5B to the P4 promoter
    Rocha-Viegas, Luciana
    Vicent, Guillermo P.
    Baranao, Jose L.
    Beato, Miguel
    Pecci, Adali
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (09)
  • [38] Regulation of lymphoid apoptosis by bcl-2 and bcl-x(L)
    Nunez, G
    Merino, R
    Simonian, PL
    Grillot, DAM
    MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION VI: CELL CYCLE AND PROGRAMMED CELL DEATH IN THE IMMUNE SYSTEM, 1996, 406 : 75 - 82
  • [39] THE FATE OF ERYTHROID PROGENITOR CELLS
    KOURY, MJ
    KELLEY, LL
    BONDURANT, MC
    MOLECULAR, CELLULAR, AND DEVELOPMENTAL BIOLOGY OF ERYTHROPOIETIN AND ERYTHROPOIESIS, 1994, 718 : 259 - 270
  • [40] T cell costimulation through CD28 depends on induction of the Bcl-xγ isoform:: Analysis of Bcl-xγ-deficient mice
    Ye, QR
    Press, B
    Kissler, S
    Yang, XF
    Lu, LR
    Bassing, CH
    Sleckman, BP
    Jansson, M
    Panoutsakopoulou, V
    Trimble, LA
    Alt, FW
    Cantor, H
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (01): : 87 - 95